Gila Therapeutics, Inc.
We are developing a simple and safe therapy to address the $150B obesity market. Far more effective than existing therapies with zero safety issues.
"Feel Full Faster"
Gila is developing a pharmaceutical product that delivers a natural human protein to the tongue to induce fullness by stimulating the satiety center in the brain. We are developing a simple and safe solution for the obesity epidemic and expect to receive FDA approval within five years though we plan to partner with a large pharma within three years for marketing and sales, and to support development.